Our recent study showed that GANT61, a Gli1 inhibitor, is able to control the growth of thyroid cancer stem cell-derived tumor but not effective to control the growth of bulk cell-derived tumors in a xenograft mouse model9. Here, GLI1 is linked to thyroid cancer.